jeudi 17 mars 2016

Onco Actu du 17 mars 2016


2.11 Etiologie - Alimentation

From the Journals: High Glycemic Index Associated With Increased Risk of Lung Cancer [CANCER RESEARCH Catalyst]

3.1 Tabac

Plans to ban e-cigarettes in public places defeated [The Telegraph]

Graphic cigarette warnings not in keeping with Chinese traditions, official says [Reuters]

4. Dépistage, diagnostic et pronostic

Ultra-sensitive Test For Cancers & HIV Developed By Stanford Chemists [Scope Blog]

4.1 Dép., diag. & prono. - Prostate

Evaluation of a Single Metastasis in Metastatic Prostate Cancer [ESMO]

5.10 Traitements - Essais

Recalibrating cancer clinical trials [National Cancer Institute]

5.12 Immunothérapies

Cellectis and MabQuest Announce Immunotherapy Partnership on New Class of PD-1 Antagonist Monoclonal Antibodies [Cellectis]

Cholesterol pill boosts cancer immunotherapy, at least in mice [Reuters]

5.12.2 Immunothérapies - CAR-T

GSK adds Miltenyi Biotec to its oncology shopping CAR-T as Witty checks out [FierceBiotech]

5.2 Pharma

Sir Andrew Witty announces decision to step down as CEO of GSK [Pharmafile]

Gilead Cancer Business Loses Top Exec Prior to Study Halts [TheStreet]

5.3 Traitements - FDA, EMA,...

EMA Offers Updated Draft Guidance on Human Clinical Trials for Cancer Drugs [RAPS]

5.4 Traitements - Economie

Using Generic Cancer Drug Could Save Many Millions of Dollars [Johns Hopkins]

NICE says 'no' to talimogene laherparepvec in melanoma [European Pharmaceutical Review]

Faster access to effective cancer treatments through new Cancer Drugs Fund [NICE]

UK cost agency rejects Amgen's virus-based cancer drug [Reuters]

5.9 AACR

Bristol-Myers Squibb to Present New Overall Survival Data for Opdivo® (nivolumab) as Monotherapy and in Combination with Yervoy® (ipilimumab) at the AACR 2016 Annual Meeting [BMS]

6. Lutte contre les cancers

'More research is needed': empty cliché or words to live by? [The Guardian]

6.10 Politiques

Why health agencies will be pleased with Merrick Garland [STAT]

The Budget 2016: a surprise sugar tax and (some) good news on tobacco [Cancer Research UK]

6.4 Médico-éco

Obama Plans To Use Value Pricing To Rein In Medicare Drug Costs [NPR]

6.9 Controverses

"Evidence-based medicine has been hijacked:" A confession from John Ioannidis [Retraction Watch]